E rythromycin is a wide-spectrum macrolide antibiotic. One of its advantages is that serious
adverse reactions are rare; the most common side effect is gastrointestinal disturbance …

Bilateral sensorineural hearing loss developed in a 64-year-old woman treated with
intravenous erythromycin lactobionate for bacteremic pneumococcal pneumonia …

Erythromycin is considered one of the safest antibiotics in common use today. In its
otolaryngologic use, the authors have found it effective in treating acute suppurative sinusitis …

Three patients are presented who developed reversible sensorineural hearing losses during
treatment with intravenous erythromycin lactobionate. A fourth patient treated with …

We report a case of bilateral hearing loss in a patient treated with intravenous erythromycin
lactobionate. The ototoxic reaction occurred despite the patient's having normal renal and …

• Thirty-two cases of sudden, symmetrical, high-frequency, sensorineural hearing loss
associated with intravenous (IV) and oral erythromycin therapy have been published since …

The side effects of erythromycin are well known. Difficulty in hearing is only rarely reported (I,
2, 4). Since very little of the drug is excreted in the urine, full doses may be given afely to …

Ototoxic liability of erythromycin and analogues. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

Irreversible Ototoxic Effect of Erythromycin: Scandinavian Audiology: Vol 15, No 1 Skip to
Main Content Taylor and Francis Online homepage Taylor and Francis Online homepage …

• A left upper lobe pneumonia developed in a patient who was receiving hemodialysis; he
was treated intravenously with 1 g of erythromycin lactobionate every six hours. After five …